GDF15 and benign prostatic hyperplasia: In contrast, only MIC-1 can precisely classify 91.2% of BPH cases compared to HC, 71.8% of BPH + PC cases compared to HC, 96.5% of PC cases compared to HC, and 87.6% of PC cases compared to BPH.